A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...
Modern vaccines are vastly safer. But then, they ought to be. Unlike most medicines, vaccines are given to people who aren’t ill and require no treatment. The bar for safety and effectiveness is ...